Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2022-03-10 00:00:00 ET · period of report 2022-03-08 · accession 0001209191-22-017840 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-10 | 2022-03-08 | IRWD | MCCOURT Thomas A | CEO, Dir | A - Grant | $0.00 | +248.9K | 835.2K | +42% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-03-08 | A | A | 248,869 | $0.00 | 835,189 | D | — | — |